Gyre Therapeutics Stock Forecast

Sell candidate since Jul 09, 2026 Loss -4.96%

The Gyre Therapeutics, Inc. stock price fell by -4.96% on the last day (Friday, 10th Jul 2026) from $6.86 to $6.52. During the last trading day the stock fluctuated 5.92% from a day low at $6.50 to a day high of $6.89. The price has fallen in 5 of the last 10 days but is still up by 4.65% over the past 2 weeks. Volume has increased on the last day by 6 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 67 thousand shares were bought and sold for approximately $436.05 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -19.32% during the next 3 months and, with a 90% probability hold a price between $3.89 and $5.81 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

GYRE Signals & Forecast

The Gyre Therapeutics, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $6.91. On a fall, the stock will find some support from the long-term average at approximately $6.23. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 02, 2026, and so far it has fallen -11.17%. Further fall is indicated until a new bottom pivot has been found. Gyre Therapeutics, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Gyre Therapeutics, Inc. stock

Gyre Therapeutics, Inc. finds support from accumulated volume at $6.29 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.385 between high and low, or 5.92%. For the last week, the stock has had daily average volatility of 5.06%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GYRE) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect Gyre Therapeutics, Inc. to open at $6.64, and during the day (based on 14 day Average True Range), to move between $6.35 and $6.69, which gives a possible trading interval of +/-$0.346 (+/-5.45%) up or down from last closing price. If Gyre Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 5.45% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $6.29 (3.53%) than the resistance at $6.86 (5.21%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Gyre Therapeutics, Inc. stock A Buy?

Gyre Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.458 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $6.64 ( 1.76%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk